In Vivo Targeting of T-Cells with Antibody- and Cytokine Conjugated Liposomes

Invention type: Technology / Case number: #16405H

Researchers

Yiran Zheng / Yuan Zhang / Brandon Kwong / Darrell Irvine

Departments: Department of Biological Engineering

Technology Areas: Biotechnology: Cell Separation, Sensors & Monitoring / Therapeutics: Proteins & Antibodies

Impact Areas: Healthy Living

in vivo targeting of cells with ligand-conjugated particles
European Patent Convention | Granted | 3,010,528
in vivo targeting of t-cells with ligand-conjugated particles
Canada | Published application
in vivo targeting of cells with ligand-conjugated particles
Switzerland | Granted | 3,010,528
in vivo targeting of cells with ligand-conjugated particles
Germany | Granted | 3,010,528
in vivo targeting of cells with ligand-conjugated particles
France | Granted | 3,010,528
in vivo targeting of cells with ligand-conjugated particles
United Kingdom | Granted | 3,010,528
in vivo targeting of cells with ligand-conjugated particles
Italy | Granted | 3,010,528
in vivo targeting of cells with ligand-conjugated particles
Netherlands | Granted | 3,010,528
in vivo targeting of cells with ligand-conjugated particles
Sweden | Granted | 3,010,528
in vivo targeting of cells with ligand-conjugated particles
United States of America | Published application

Interested in this technology? Connect with our experienced licensing team to initiate the process.